FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387047007: Loteprednol etabonate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1763813019 Loteprednol etabonate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1776051014 Loteprednol etabonate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1461225014 Loteprednol etabonate ophthalmic preparation (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1481161016 Loteprednol etabonate ophthalmic preparation en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1763813019 Loteprednol etabonate (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1763813019 Loteprednol etabonate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1776051014 Loteprednol etabonate en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1776051014 Loteprednol etabonate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
821621000172114 lotéprednol etabonate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
821621000172114 lotéprednol etabonate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Loteprednol etabonate (substance) Is a Adrenal cortex hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate (substance) Is a Glucocorticoid hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate (substance) Is a Loteprednol (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate (substance) Is modification of (attribute) Loteprednol (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate (substance) Is a Synthetic glucocorticoid false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate (substance) Has disposition Androgen receptor agonist (disposition) false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate (substance) Has disposition Gonadal hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate (substance) Is a Androstane true Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate (substance) Is a Glucocorticoid (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate (substance) Is a Antilipemic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate (substance) Has disposition Hormone (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Loteprednol etabonate ophthalmic preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Loteprednol etabonate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter conventional release eye suspension (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Loteprednol etabonate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 2 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Loteprednol etabonate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Loteprednol etabonate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate + tobramycin The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Loteprednol etabonate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Loteprednol etabonate (substance) Inferred relationship Existential restriction modifier (core metadata concept)
Loteprednol etabonate 2 mg/mL eye suspension Has precise active ingredient True Loteprednol etabonate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Loteprednol etabonate 2 mg/mL eye suspension Has basis of strength substance (attribute) True Loteprednol etabonate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter conventional release eye suspension (clinical drug) Has basis of strength substance (attribute) True Loteprednol etabonate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely loteprednol etabonate 5 milligram/1 milliliter conventional release eye suspension (clinical drug) Has precise active ingredient True Loteprednol etabonate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 1
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has precise active ingredient True Loteprednol etabonate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension Has basis of strength substance (attribute) True Loteprednol etabonate (substance) Inferred relationship Existential restriction modifier (core metadata concept) 2

This concept is not in any reference sets

Back to Start